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Abstract
The presence of acanthocytes in the blood is characteristic of patients suffering from neuroacanthocytosis (NA). Recent studies have described abnormal
phosphorylation of the proteins involved in connecting the membrane and cytoskeleton in patient-derived erythrocytes. The involvement of lipids in the underlying
signaling pathways and recent reports on in vitro disease-associated lipid alterations support renewed research into lipid composition, signal transduction, and
metabolism in patient erythrocytes. In addition to morphology, changes in membrane organization affect erythrocyte function and survival. Patient erythrocytes
may have a decreased ability to deform, and this may contribute to accelerated erythrocyte removal and a decreased oxygen supply, especially in vulnerable brain
regions. The presently available data indicate that acanthocytes are likely to originate in the bone marrow, making erythropoiesis an obvious new focus in NA
research. Moreover, new, detailed morphological observations indicate that acanthocytes may be the tip of the iceberg with regard to misshapen erythrocytes in the
circulation of patients with NA.
A systematic assessment of patient erythrocyte morphology, deformability, oxygen delivery, and metabolism will be instrumental in determining the putative
contribution of erythrocyte function to NA clinical symptoms.
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Neuroacanthocytosis: an introduction
Patients suffering from a neuroacanthocytosis (NA) syndrome
experience neurological symptoms due to basal ganglia degeneration,
and their blood contains acanthocytes with thorn-like protrusions.
Genes mutated in patients with chorea-acanthocytosis (ChAc),
McLeod syndrome (MLS), and Huntington’s disease-like 2 (HDL-2)
have been identified, but neither the functions of the proteins they
encode nor the pathophysiologic processes caused by these mutations
are well understood. There is also limited knowledge regarding the
causes of neurodegeneration with brain iron accumulation (NBIA)
such as pantothenate kinase-associated neurodegeneration (PKAN),
where the functions of the affected gene products center around lipid
modification and metabolism.1,2 Given the paucity of relevant
phenotypes in currently available cellular and animal models, research
into the molecular causes of acanthocyte formation and consequences
could be performed using easily accessible erythrocytes. This feasible
approach could identify mechanisms underlying neurodegenerative
processes. Here, we present an inventory of the actual knowledge and
current hypotheses, as well as some of our ideas on the most fruitful
approaches for unraveling the molecular mechanisms behind acantho-
cyte formation and subsequent neurodegeneration.
Acanthocyte generation
Acanthocytosis is associated with NA syndromes, but the presence
and number of acanthocytes are inconsistent. An overview of the
published data suggests that considerable acanthocytosis is associated
with MLS, but it is much more variable in ChAc, HDL-2, and
PKAN.1,2 Anecdotal evidence indicates that the fraction of acantho-
cytes varies in individual patients over time, without a clear association
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with clinical symptoms (G. Irvine, personal communication). This
seems to exclude the possibility that the transition of possibly
susceptible erythrocytes with a normal, discocyte morphology to an
acanthocyte is secondary to mechanical stress due to involuntary
movements or seizures. This view is supported by the inability to
(bio)chemically induce acanthocyte formation in vitro and by the
normal deformability of both acanthocytes and discocytes of NA
patients in a capillary-mimicking system.3 In addition, detailed
microscopic analyses have shown that methodological aspects cannot
be underestimated in distinguishing between acanthocytes and
erythrocytes with an acanthocyte-like morphology.3,4 The issue
remains unresolved given the complexity of clinical symptoms in
patients with NA and the likely but largely unknown effects of many
drugs on erythrocyte membrane characteristics.5 This matter may be
even more complex because acanthocytes may not be the only
erythrocytes with an aberrant shape in patients with NA or their
relatives.3 Thus, a meaningful interpretation of acanthocytosis data is
hampered by the lack of a systematic inventory of the numbers of
acanthocytes and other misshapen erythrocytes in patients and
nonaffected family members, as well as changes in these numbers
over time.
The possible role of membrane-cytoskeleton interactions
It is not clear why erythrocytes and basal ganglia neurons are
specifically affected in NA. Erythrocyte morphology depends largely
on the ankyrin and junctional complexes that link the plasma
membrane to the spectrin-actin cytoskeleton.6,7 Phosphorylation
regulates the composition of these complexes and thereby influences
the strength and type of cytoskeleton linkages.8 The proteins involved
in erythrocyte membrane-cytoskeleton interactions are expressed in
neurons. Interestingly, specific ankyrin-R splice variants9 and
b-adducin10 are only expressed in brain tissue and erythrocytes.
Disturbances in connectivity between the cytoskeleton and plasma
membrane often have pathologic consequences for erythrocytes6,7 and
may lead to neuronal death.11 In addition, membrane-cytoskeleton
interactions and activities are regulated by lipids in both cell types. For
example, the cytoskeleton proteins b-spectrin and protein 4.1 bind to
both ankyrin and the phosphoinositide PtdIns(4,5)P2 through a
pleckstrin homology (PH) domain or FERM domain, respectively,
and this may affect erythrocyte morphology and neuronal glutamate
transporter activity.12–15
Membrane lipid involvement
Numerous studies have focused on defining the composition and/or
organization of the acanthocyte membrane. Because the main known
cause of acanthocytosis is the effect of betalipoproteinemia-associated
lipid metabolism disturbance,16 research into lipid abnormalities is an
obvious focus. In general, this approach has not generated any data
that clearly indicate altered lipid composition in the erythrocyte
membrane as a pivotal factor in NA. Phospholipid analysis has not
revealed any consistent differences in the relative amounts of the main
phospholipid classes or membrane cholesterol in erythrocytes from NA
patients compared with those of control donors.17,18 This statement
was corroborated by a detailed semi-quantitative analysis of the
erythrocyte membrane fatty acid composition.19 Currently available
sensitive and specific mass spectrometric analysis methods to generate
lipidomic data have not yet been applied to this field. However,
quantitative analyses may not reveal local alterations in membrane
composition (e.g., microdomain distribution and composition). In view
of the known role of lipid organization in membrane behavior (see
above) and the likely involvement of NBIA gene products in lipid
metabolism,2 minor changes in lipid composition may turn out to be
instrumental for the acanthocytic shape. This supposition is supported
by recent findings in both yeast and human cells, showing that
knockout of VPS13A (the gene that encodes chorein, the protein
affected in ChAc patients) leads to a decrease in the phosphoinositide
PtdIns4P.20,21 In addition, heterogeneity in the erythrocyte population,
in particular the percentage of clearly identifiable acanthocytes,3 may
have obscured the presence of cell morphology-specific alterations in
lipid organization. This suggests that it may be worthwhile to
reinvestigate this issue using presently available cell separation
methods and lipidomic analysis technologies. Together with the
known possibility of influencing membrane lipid composition—and
possibly neurodegeneration—by diet interventions,22,23 molecular
identification of a lipid metabolism flaw in erythrocytes would
constitute an interesting starting point for the development of novel
treatments.
Proteins involved in acanthocyte formation
Protein staining of the membrane fractions of erythrocytes from
patients with NA has failed to reveal any conspicuous aberrations.
However, immunochemical analyses showed consistently abnormal
patterns using antibodies against band 3.19,24 Subsequent data
suggested that these patterns arise from acanthocytosis-associated
degradation that especially affect the N-terminal, cytoplasmic domain
of band 3.25 It has to be noted that this approach (i.e., an investigation
of acanthocytosis-associated alterations using specific antibodies) was
mainly triggered by the description of altered band 3 structure and
function in acanthocytosis,26 and this has not been systematically
assessed for other erythrocyte membrane proteins. Recent data from
proteomic inventories have triggered other approaches. These
inventories of erythrocyte membrane fractions from patients with
ChAc, MLS, and HDL-2 have revealed both acanthocytosis-associated
quantitative changes in membrane protein composition revolving
around band 3 and data suggesting that these changes are caused by
alterations in phosphorylation-mediated protein-protein interac-
tions.25,27 These observations led to findings suggesting that alterations
in signaling pathways associated with altered membrane recruitment
and/or abnormal activity of the Src-family kinase (SFK) Lyn are
primarily responsible for decreased band 3-mediated binding of the
cytoskeleton to the lipid bilayer in ChAc patients.27 A relationship
between the absence of chorein, altered cytoskeleton organization, and
protein phosphorylation was confirmed in a report that phosphoryla-
tion of the PI3K subunit p85 was decreased in erythrocytes from ChAc
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patients. This was associated with decreased phosphorylation and
activation of its substrates PAK1 and Rac1 and an apparent decrease
in actin polymerization.28,29
NA pathways
Recent years have witnessed a transition in research into NA
erythrocytes from a hypothesis-driven to a phenomenological
approach. The latter was almost immediately followed by investigation
into the signaling pathways regulating (abnormal) protein–protein
interactions in acanthocytes. This suggests that the field is influenced
by the growing awareness that regulation of erythrocyte structure and
function is intimately interwoven with organismal homeostasis. The
emerging question is: how can the current knowledge regarding
regulation of erythrocyte shape contribute to insight into the
mechanisms leading to the acanthocyte shape and possibly to altered
erythrocyte function? An overview of the current knowledge regarding
the causes of aberrant erythrocyte morphology in genetic membrano-
pathies reveals many molecular and structural details regarding the
interaction between integral and cytoskeletal proteins. Unfortunately,
little is known about the underlying signaling pathways.6,7 Upon
comparing the current knowledge on acanthocytosis with that of
specific erythrocyte membranopathies, we have to conclude that the
theory that disturbance of band 3-cytoskeleton interactions induces
acanthocytosis lacks sufficient heuristic value. Indeed, there is one
band 3 mutation that is associated with acanthocytosis,26 but
numerous others lack acanthocytes as a prominent feature.
Moreover, the blood of individuals with mutations in other proteins
of membrane-cytoskeleton complexes contains many more spherocytes
or elliptocytes than acanthocytes.6,7 In addition, altered phosphoryla-
tion of band 3 involving Lyn and related protein kinases induces
changes in band 3 organization that have not been described in
acanthocytes.8,30 Finally, attempts to generate acanthocytes in vitro by
disturbance of vertical and/or horizontal protein–protein interactions
have not been successful. For example, disturbance of the phosphor-
ylation status confirmed previous data that the transition from a
discocyte to an echinocytic shape can be induced by increased band 3
phosphorylation,8,30 but the often postulated transition from an
echinocytic to a clearly identifiable acanthocytic shape has not been
published. This implies that the presence of acanthocytes is a highly
specific phenomenon in patients with NA. This is the more surprising
given that the known genetic causes of NA involve proteins with very
diverse functions, none of which are presently known to be specific or
critically important for mature erythrocytes.
Autophagy
An elegant model combines the various molecular details of NA into
a hypothesis that centers on autophagy dysfunction.31 Indeed, flaws in
autophagy have been reported in several neurodegenerative
diseases11,32 and may influence erythrocyte differentiation during
erythropoiesis.33 Active class I PI3K is known to inhibit autop-
hagy,34,35 so a decrease in its activity as described in chorein-deficient
cells would be expected to increase autophagy. However, such
decreased activity may also constitute a compensatory mechanism,
as has been postulated to explain the late onset of Huntington’s
disease.36,37 Abnormal Lyn activity in ChAc erythrocytes may
constitute another counteracting mechanism as Lyn activity may
promote autophagy.38 The phosphoinositides PtdIns4P and
PtdIns(4,5)P2 regulate membrane-cytoskeleton interactions (see above)
and are emerging as important players in the autophagy process.39
The development of tools that allow on-demand lipid and kinase
manipulation is needed to investigate their influence on erythrocyte
shape.
Defective erythrocyte function and brain hypoperfusion
Most erythrocyte malformations have clinical consequences through
decreased cell survival and secondary pathology,6,7 but this is much
less conspicuous in patients with NA. Clinical descriptions of patients
with NA concentrate on neurological and neuromuscular symptoms
and are sparse in indications of hemolysis or anemia. However,
decreased erythrocyte deformability and increased erythrocyte loss, as
implied by splenomegaly, may be more common than suggested by the
few descriptions in patients with McLeod disease.1,40 Recent in vitro
findings showing decreased passage of acanthocytes and other
erythrocytes from PKAN patients through a spleen-mimicking device
point toward a general phenomenon.3 A reduction in haptoglobin, a
marker for hemolysis, has been reported in several patients.1,40 This
suggests that acanthocytes have a decreased capacity for extensive
deformability.
Decreased deformability is associated with anemia, and even
subclinical deformability can hamper oxygen delivery. The striatum,
which is the part of the basal ganglia most severely afflicted in patients
with NA, is also highly sensitive to hypoperfusion.41 Oxygen
deprivation leads to excessive glutamate release in the brain and
subsequent overactivation of N-methyl-D-aspartate (NMDA)-receptors
and cell death. Various reports have shown that NMDA-receptor
activity is increased by Src family kinases.42 Moreover, the activity of
these kinases is increased under hypoxic circumstances, providing a
possible explanation for abnormal Lyn activation in ChAc patients.
Medium spiny neurons, the most afflicted cells in NA, are more
susceptible than striatal interneurons to excitotoxic damage,43 and the
selective loss of specific striatal neuronal subpopulations in a mouse
model of Huntington’s disease correlates with motor symptoms similar
to those observed in NA patients.44
Insufficient erythrocyte deformability, aggravated by hypoxic
circumstances, may exacerbate hypoperfusion. Recent perfusion and
metabolic imaging studies have shown impairment of brain perfusion
in patients with sickle cell anemia,45 which may contribute to the
recently observed deficiencies in cognitive functioning in sickle cell
patients.46 Hypoperfusion has also been described in a NA patient
using various imaging methods,47 underscoring the validity of
investigating microvascular blood flow in the brain of patients with
NA. Thus, hypoperfusion caused by erythrocyte dysfunction may
provide a partial explanation for neuropathologic changes in patients
with NA.
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The where and when of acanthocyte generation have been largely
neglected. Do acanthocytes evolve from normal, susceptible discocytes
in circulation, or are they derived from bone marrow? Also, could NA-
associated disturbance of neuronal homeostasis in the central nervous
system affect erythropoiesis as suggested by reports on the involvement
of nerve cells in the regulation of hematopoietic stem cell kinetics?48,49
The answers to these questions have implications for future research
strategies: if acanthocytes are already formed in the bone marrow,
investigation of the underlying mechanisms is likely to yield more
insight, especially if we focus on genes currently known to be mutated
in NA. If acanthocytes are formed in circulation, identifying the factors
that induce this transition and its molecular and/or functional
consequences may be more effective. From this perspective, an
overview of the currently available—albeit circumstantial—evidence
indicates that the acanthocytic shape may already be present upon
appearance in the circulation. 1) There are no data suggesting that the
acanthocytic shape increases with erythrocyte age in patients with NA.
On the contrary: the percentage of acanthocytes in control donors is
highest in cell fractions that contain the youngest erythrocytes.25 2)
There is no known association between the extent of acanthocytosis
and the severity or nature of neuromuscular symptoms. 3) It has not
been possible to induce acanthocytosis in vitro or to generate discocytes
from patient-derived acanthocytes. 4) An increased amount of fetal
hemoglobin in acanthocyte-enriched cell fractions indicates disturbed
erythropoiesis in patients with NA.3
Conclusion
The present overview of the available data supports the conclusion
that erythrocyte-centered and acanthocyte-inspired research
approaches remain instrumental to developing a better understanding
of NA pathophysiology. Important goals include: 1) the effect of NA-
associated mechanisms on erythrocyte structure and function, 2) a
detailed comparative study of the characteristics of relevant signaling
pathways in erythrocytes from patients with various forms of
acanthocytosis other than ChAc, and 3) the effect of acanthocytosis
on oxygen delivery.
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